Cholera Vaccines Market Analysis

Cholera Vaccines Market Analysis

To get key market trends

  Download Free Sample

Based on the product, the market is categorized as Dukoral, Vaxchora, Euvichol/Euvichol-Plus, and other products. The Euvichol/Euvichol-Plus product segment is set to lead the market, accounting for the largest revenue of USD 40.4 million in 2023, anticipating its dominance throughout the forecast period with a CAGR of 8.2%.
 

• Euvichol and Euvichol-Plus vaccines are in high demand and widely adopted for mass campaigns due to their effectiveness, ease of administration, and affordability. These oral cholera vaccines are favored for large-scale immunization efforts, particularly in regions prone to cholera outbreaks. Therefore, their proven track record in preventing cholera, coupled with support from global health organizations and governments will drive the market demand.
   

Based on end-user, the cholera vaccines market is classified into Public and private. The public segment holds the largest market share of 80.8% in 2023 and is expected to maintain dominance throughout the analysis period.
 

• These healthcare facilities are primary points of contact for patients, making them essential for widespread vaccine distribution and administration. In January 2024, Zimbabwe launched a cholera vaccination campaign on Monday to immunize over 2 million people against the waterborne disease, aiming to curb an ongoing outbreak that has claimed hundreds of lives since last year. The campaign, supported by UNICEF and the WHO, will distribute a total of 2.3 million vaccine doses across 29 severely affected districts. This collaborative effort and government support aimed to address the global concern of cholera surging the need for vaccines.
   
• Therefore, public health campaigns and collaborate with government and international organizations to conduct mass vaccination drives significantly boosting the cholera vaccine market.
   

Canada dominated the North American cholera vaccines market accounting for USD 19.3 million in 2023 and is anticipated to show considerable growth over the analysis period.
 

• Canada's prominence was attributed to its comprehensive healthcare system, proactive public health policies, and high vaccination coverage. The country's stringent regulatory standards ensure the safety and efficacy of vaccines, fostering confidence among healthcare providers and the public.
   
• Additionally, Canada's strategic partnerships with vaccine manufacturers and international health organizations facilitate timely access to vaccines and support for nationwide immunization campaigns. These factors collectively enhance Canada's prominence in driving demand for cholera vaccines in the North American region.
   

The UK exhibited a high growth potential in the European cholera vaccines market.
 

• The UK government supports public health initiatives and provides funding for vaccine research and immunization programs. This commitment enhanced the country’s capacity to contribute significantly to the cholera vaccine market.
   
• Further, the country's collaboration with international organizations such as the WHO and Gavi plays a pivotal role in global cholera vaccination efforts. These partnerships enhance the UK's influence in the European cholera vaccine market.
   

The Asia Pacific leads the cholera vaccines market with a share of 41.5% in 2023 poised to grow with a CAGR of 8.7%.
 

• The high incidence of cholera outbreaks in Asia Pacific countries is driven by inadequate sanitation and water infrastructure. This situation fuels the demand for effective vaccination programs.
   
• For instance, according to the European Centre for Disease Prevention and Control (ECDC), from April 15, 2024, to May 30, 2024, 449 new cholera cases have been reported. Since January 1, 2024, a total of 1,769 cases, including four deaths, have been documented. In contrast, by May 19, 2023, 616 cases were reported. This significant increase highlighted the growing urgency for effective cholera prevention and control measures.
   
• Therefore, the strong governmental efforts to combat cholera, including mass vaccination campaigns and public health initiatives, contribute significantly to the region’s market growth.